Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elin Lehrmann is active.

Publication


Featured researches published by Elin Lehrmann.


Scientific Reports | 2011

SRT1720 improves survival and healthspan of obese mice

Robin K. Minor; Joseph A. Baur; Ana P. Gomes; Theresa M. Ward; Anna Csiszar; Evi M. Mercken; Kotb Abdelmohsen; Yu Kyong Shin; Carles Cantó; Morten Scheibye-Knudsen; Melissa Krawczyk; Pablo M. Irusta; Alejandro Martin-Montalvo; Basil P. Hubbard; Yongqing Zhang; Elin Lehrmann; Alexa A. White; Nathan L. Price; William R. Swindell; Kevin J. Pearson; Kevin G. Becker; Vilhelm A. Bohr; Myriam Gorospe; Josephine M. Egan; Mark I. Talan; Johan Auwerx; Christoph H. Westphal; James L. Ellis; Zoltan Ungvari; George P. Vlasuk

Sirt1 is an NAD+-dependent deacetylase that extends lifespan in lower organisms and improves metabolism and delays the onset of age-related diseases in mammals. Here we show that SRT1720, a synthetic compound that was identified for its ability to activate Sirt1 in vitro, extends both mean and maximum lifespan of adult mice fed a high-fat diet. This lifespan extension is accompanied by health benefits including reduced liver steatosis, increased insulin sensitivity, enhanced locomotor activity and normalization of gene expression profiles and markers of inflammation and apoptosis, all in the absence of any observable toxicity. Using a conditional SIRT1 knockout mouse and specific gene knockdowns we show SRT1720 affects mitochondrial respiration in a Sirt1- and PGC-1α-dependent manner. These findings indicate that SRT1720 has long-term benefits and demonstrate for the first time the feasibility of designing novel molecules that are safe and effective in promoting longevity and preventing multiple age-related diseases in mammals.


Glia | 2013

Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes.

Emmette R. Hutchison; Elisa Mitiko Kawamoto; Dennis D. Taub; Ashish Lal; Kotb Abdelmohsen; Yongqing Zhang; William H. Wood; Elin Lehrmann; Simonetta Camandola; Kevin G. Becker; Myriam Gorospe; Mark P. Mattson

Inflammation is a common component of acute injuries of the central nervous system (CNS) such as ischemia, and degenerative disorders such as Alzheimers disease. Glial cells play important roles in local CNS inflammation, and an understanding of the roles for microRNAs in glial reactivity in injury and disease settings may therefore lead to the development of novel therapeutic interventions. Here, we show that the miR‐181 family is developmentally regulated and present in high amounts in astrocytes compared to neurons. Overexpression of miR‐181c in cultured astrocytes results in increased cell death when exposed to lipopolysaccharide (LPS). We show that miR‐181 expression is altered by exposure to LPS, a model of inflammation, in both wild‐type and transgenic mice lacking both receptors for the inflammatory cytokine TNF‐α. Knockdown of miR‐181 enhanced LPS‐induced production of pro‐inflammatory cytokines (TNF‐α, IL‐6, IL‐1β, IL‐8) and HMGB1, while overexpression of miR‐181 resulted in a significant increase in the expression of the anti‐inflammatory cytokine IL‐10. To assess the effects of miR‐181 on the astrocyte transcriptome, we performed gene array and pathway analysis on astrocytes with reduced levels of miR‐181b/c. To examine the pool of potential miR‐181 targets, we employed a biotin pull‐down of miR‐181c and gene array analysis. We validated the mRNAs encoding MeCP2 and X‐linked inhibitor of apoptosis as targets of miR‐181. These findings suggest that miR‐181 plays important roles in the molecular responses of astrocytes in inflammatory settings. Further understanding of the role of miR‐181 in inflammatory events and CNS injury could lead to novel approaches for the treatment of CNS disorders with an inflammatory component.


Circulation Research | 2012

Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis

Harald Langer; Eun Young Choi; Hong Zhou; Rebecca Schleicher; Kyoung-Jin Chung; Zhongshu Tang; Kerstin Göbel; Khalil Bdeir; Antonios Chatzigeorgiou; Connie Hoi Yee Wong; Sumeena Bhatia; Michael J. Kruhlak; John Rose; James Burns; Kenneth E. Hill; Yongqing Zhang; Elin Lehrmann; Kevin G. Becker; Yunmei Wang; Daniel I. Simon; Bernhard Nieswandt; John D. Lambris; Xuri Li; Sven G. Meuth; Paul Kubes; Triantafyllos Chavakis

Rationale: Multiple sclerosis (MS) and its mouse model, experimental autoimmune encephalomyelitis (EAE), are inflammatory disorders of the central nervous system (CNS). The function of platelets in inflammatory and autoimmune pathologies is thus far poorly defined. Objective: We addressed the role of platelets in mediating CNS inflammation in EAE. Methods and Results: We found that platelets were present in human MS lesions as well as in the CNS of mice subjected to EAE but not in the CNS from control nondiseased mice. Platelet depletion at the effector-inflammatory phase of EAE in mice resulted in significantly ameliorated disease development and progression. EAE suppression on platelet depletion was associated with reduced recruitment of leukocytes to the inflamed CNS, as assessed by intravital microscopy, and with a blunted inflammatory response. The platelet-specific receptor glycoprotein Ib&agr; (GPIb&agr;) promotes both platelet adhesion and inflammatory actions of platelets and targeting of GPIb&agr; attenuated EAE in mice. Moreover, targeting another platelet adhesion receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), also reduced EAE severity in mice. Conclusions: Platelets contribute to the pathogenesis of EAE by promoting CNS inflammation. Targeting platelets may therefore represent an important new therapeutic approach for MS treatment.


Nature | 2016

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

Amanpreet Kaur; Marie R. Webster; Katie Marchbank; Reeti Behera; Abibatou Ndoye; Curtis H. Kugel; Vanessa Dang; Jessica Appleton; Michael P. O'Connell; Phil F. Cheng; Alexander Valiga; Rachel Morissette; Nazli B. McDonnell; Luigi Ferrucci; Andrew V. Kossenkov; Katrina Meeth; Hsin Yao Tang; Xiangfan Yin; William H. Wood; Elin Lehrmann; Kevin G. Becker; Keith T. Flaherty; Dennie T. Frederick; Jennifer A. Wargo; Zachary A. Cooper; Michael T. Tetzlaff; Courtney W. Hudgens; Katherine M. Aird; Rugang Zhang; Xiaowei Xu

Cancer is a disease of ageing. Clinically, aged cancer patients tend to have a poorer prognosis than young. This may be due to accumulated cellular damage, decreases in adaptive immunity, and chronic inflammation. However, the effects of the aged microenvironment on tumour progression have been largely unexplored. Since dermal fibroblasts can have profound impacts on melanoma progression, we examined whether age-related changes in dermal fibroblasts could drive melanoma metastasis and response to targeted therapy. Here we find that aged fibroblasts secrete a Wnt antagonist, sFRP2, which activates a multi-step signalling cascade in melanoma cells that results in a decrease in β-catenin and microphthalmia-associated transcription factor (MITF), and ultimately the loss of a key redox effector, APE1. Loss of APE1 attenuates the response of melanoma cells to DNA damage induced by reactive oxygen species, rendering the cells more resistant to targeted therapy (vemurafenib). Age-related increases in sFRP2 also augment both angiogenesis and metastasis of melanoma cells. These data provide an integrated view of how fibroblasts in the aged microenvironment contribute to tumour progression, offering new possibilities for the design of therapy for the elderly.


PLOS ONE | 2011

Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity

Wayne Chadwick; Nicholas Mitchell; Jenna Caroll; Yu Zhou; Sung-Soo Park; Liyun Wang; Kevin G. Becker; Yongqing Zhang; Elin Lehrmann; William H. Wood; Bronwen Martin; Stuart Maudsley

Approximately 35 million people worldwide suffer from Alzheimers disease (AD). Existing therapeutics, while moderately effective, are currently unable to stem the widespread rise in AD prevalence. AD is associated with an increase in amyloid beta (Aβ) oligomers and hyperphosphorylated tau, along with cognitive impairment and neurodegeneration. Several antidepressants have shown promise in improving cognition and alleviating oxidative stress in AD but have failed as long-term therapeutics. In this study, amitriptyline, an FDA-approved tricyclic antidepressant, was administered orally to aged and cognitively impaired transgenic AD mice (3×TgAD). After amitriptyline treatment, cognitive behavior testing demonstrated that there was a significant improvement in both long- and short-term memory retention. Amitriptyline treatment also caused a significant potentiation of non-toxic Aβ monomer with a concomitant decrease in cytotoxic dimer Aβ load, compared to vehicle-treated 3×TgAD controls. In addition, amitriptyline administration caused a significant increase in dentate gyrus neurogenesis as well as increases in expression of neurosynaptic marker proteins. Amitriptyline treatment resulted in increases in hippocampal brain-derived neurotrophic factor protein as well as increased tyrosine phosphorylation of its cognate receptor (TrkB). These results indicate that amitriptyline has significant beneficial actions in aged and damaged AD brains and that it shows promise as a tolerable novel therapeutic for the treatment of AD.


Neurobiology of Disease | 2013

CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat

Irina N. Krasnova; Margarit Chiflikyan; Zuzana Justinova; Michael T. McCoy; Bruce Ladenheim; Subramaniam Jayanthi; Cynthia Quintero; Christie Brannock; Chanel Barnes; Jordan E. Adair; Elin Lehrmann; Firas Kobeissy; Mark S. Gold; Kevin G. Becker; Steven R. Goldberg; Jean Lud Cadet

Neuroplastic changes in the dorsal striatum participate in the transition from casual to habitual drug use and might play a critical role in the development of methamphetamine (METH) addiction. We examined the influence of METH self-administration on gene and protein expression that may form substrates for METH-induced neuronal plasticity in the dorsal striatum. Male Sprague-Dawley rats self-administered METH (0.1mg/kg/injection, i.v.) or received yoked saline infusions during eight 15-h sessions and were euthanized 2h, 24h, or 1month after cessation of METH exposure. Changes in gene and protein expression were assessed using microarray analysis, RT-PCR and Western blots. Chromatin immunoprecipitation (ChIP) followed by PCR was used to examine epigenetic regulation of METH-induced transcription. METH self-administration caused increases in mRNA expression of the transcription factors, c-fos and fosb, the neurotrophic factor, Bdnf, and the synaptic protein, synaptophysin (Syp) in the dorsal striatum. METH also caused changes in ΔFosB, BDNF and TrkB protein levels, with increases after 2 and 24h, but decreases after 1month of drug abstinence. Importantly, ChIP-PCR showed that METH self-administration caused enrichment of phosphorylated CREB (pCREB), but not of histone H3 trimethylated at lysine 4 (H3K4me3), on promoters of c-fos, fosb, Bdnf and Syp at 2h after cessation of drug intake. These findings show that METH-induced changes in gene expression are mediated, in part, by pCREB-dependent epigenetic phenomena. Thus, METH self-administration might trigger epigenetic changes that mediate alterations in expression of genes and proteins serving as substrates for addiction-related synaptic plasticity.


PLOS ONE | 2012

Methamphetamine Causes Differential Alterations in Gene Expression and Patterns of Histone Acetylation/Hypoacetylation in the Rat Nucleus Accumbens

Tracey Amanda Martin; Subramaniam Jayanthi; Michael T. McCoy; Christie Brannock; Bruce Ladenheim; Tiffany Garrett; Elin Lehrmann; Kevin G. Becker; Jean Lud Cadet

Methamphetamine (METH) addiction is associated with several neuropsychiatric symptoms. Little is known about the effects of METH on gene expression and epigenetic modifications in the rat nucleus accumbens (NAC). Our study investigated the effects of a non-toxic METH injection (20 mg/kg) on gene expression, histone acetylation, and the expression of the histone acetyltransferase (HAT), ATF2, and of the histone deacetylases (HDACs), HDAC1 and HDAC2, in that structure. Microarray analyses done at 1, 8, 16 and 24 hrs after the METH injection identified METH-induced changes in the expression of genes previously implicated in the acute and longterm effects of psychostimulants, including immediate early genes and corticotropin-releasing factor (Crf). In contrast, the METH injection caused time-dependent decreases in the expression of other genes including Npas4 and cholecystokinin (Cck). Pathway analyses showed that genes with altered expression participated in behavioral performance, cell-to-cell signaling, and regulation of gene expression. PCR analyses confirmed the changes in the expression of c-fos, fosB, Crf, Cck, and Npas4 transcripts. To determine if the METH injection caused post-translational changes in histone markers, we used western blot analyses and identified METH-mediated decreases in histone H3 acetylated at lysine 9 (H3K9ac) and lysine 18 (H3K18ac) in nuclear sub-fractions. In contrast, the METH injection caused time-dependent increases in acetylated H4K5 and H4K8. The changes in histone acetylation were accompanied by decreased expression of HDAC1 but increased expression of HDAC2 protein levels. The histone acetyltransferase, ATF2, showed significant METH-induced increased in protein expression. These results suggest that METH-induced alterations in global gene expression seen in rat NAC might be related, in part, to METH-induced changes in histone acetylation secondary to changes in HAT and HDAC expression. The causal role that HATs and HDACs might play in METH-induced gene expression needs to be investigated further.


Pharmacogenomics Journal | 2003

Transcriptional profiling in the human prefrontal cortex: Evidence for two activational states associated with cocaine abuse

Elin Lehrmann; Jonathan Oyler; Marquis P. Vawter; Thomas M. Hyde; Bhaskar Kolachana; Joel E. Kleinman; Marilyn A. Huestis; Kevin G. Becker; William J. Freed

ABSTRACTCNS-focused cDNA microarrays were used to examine gene expression profiles in dorsolateral prefrontal cortex (dlPFC, Area 46) from seven individual sets of age- and post-mortem interval-matched male cocaine abusers and controls. The presence of cocaine and related metabolites was confirmed by gas chromatography-mass spectrometry. Sixty-five transcripts were differentially expressed, indicating alterations in energy metabolism, mitochondria and oligodendrocyte function, cytoskeleton and related signaling, and neuronal plasticity. There was evidence for two distinct states of transcriptional regulation, with increases in gene expression predominating in subjects testing positive for a metabolite indicative of recent ‘crack’ cocaine abuse and decreased expression profiles in the remaining cocaine subjects. This pattern was confirmed by quantitative polymerase chain reaction for select transcripts. These data suggest that cocaine abuse targets a distinct subset of genes in the dlPFC, resulting in either a state of acute activation in which increased gene expression predominates, or a relatively destimulated, refractory phase.


The EMBO Journal | 2011

Global dissociation of HuR–mRNA complexes promotes cell survival after ionizing radiation

Kiyoshi Masuda; Kotb Abdelmohsen; Mihee M. Kim; Subramanya Srikantan; Eun Kyung Lee; Kumiko Tominaga; Roza Selimyan; Jennifer L. Martindale; Xiaoling Yang; Elin Lehrmann; Yongqing Zhang; Kevin G. Becker; Jian-Ying Wang; Hyeon Ho Kim; Myriam Gorospe

Ionizing radiation (IR) triggers adaptive changes in gene expression. Here, we show that survival after IR strongly depends on the checkpoint kinase Chk2 acting upon its substrate HuR, an RNA‐binding protein that stabilizes and/or modulates the translation of target mRNAs. Microarray analysis showed that in human HCT116 colorectal carcinoma cells (WT), IR‐activated Chk2 triggered the dissociation of virtually all of HuR‐bound mRNAs, since IR did not dissociate HuR target mRNAs in Chk2‐null (CHK2−/−) HCT116 cells. Accordingly, several HuR‐interacting mRNAs encoding apoptosis‐ and proliferation‐related proteins (TJP1, Mdm2, TP53BP2, Bax, K‐Ras) dissociated from HuR in WT cells, but remained bound and showed altered post‐transcriptional regulation in CHK2−/− cells. Use of HuR mutants that were not phosphorylatable by Chk2 (HuR(3A)) and HuR mutants mimicking constitutive phosphorylation by Chk2 (HuR(3D)) revealed that dissociation of HuR target transcripts enhanced cell survival. We propose that the release of HuR‐bound mRNAs via an IR‐Chk2‐HuR regulatory axis improves cell outcome following IR.


The Journal of Pathology | 2014

A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.

Cheryl A. Sherman-Baust; Elisabetta Kuhn; Blanca L. Valle; Ie Ming Shih; Robert J. Kurman; Tian Li Wang; Tomokazu Amano; Minoru Sh Ko; Ichiro Miyoshi; Yoshihiko Araki; Elin Lehrmann; Yongqing Zhang; Kevin G. Becker; Patrice J. Morin

Recent evidence suggests that ovarian high‐grade serous carcinoma (HGSC) originates from the epithelium of the fallopian tube. However, most mouse models are based on the previous prevailing view that ovarian cancer develops from the transformation of the ovarian surface epithelium. Here, we report the extensive histological and molecular characterization of the mogp–TAg transgenic mouse, which expresses the SV40 large T‐antigen (TAg) under the control of the mouse müllerian‐specific Ovgp‐1 promoter. Histological analysis of the fallopian tubes of mogp–TAg mice identified a variety of neoplastic lesions analogous to those described as precursors to ovarian HGSC. We identified areas of normal‐appearing p53‐positive epithelium that are similar to ‘p53 signatures’ in the human fallopian tube. More advanced proliferative lesions with nuclear atypia and epithelial stratification were also identified that were morphologically and immunohistochemically reminiscent of human serous tubal intraepithelial carcinoma (STIC), a potential precursor of ovarian HGSC. Beside these non‐invasive precursor lesions, we also identified invasive adenocarcinoma in the ovaries of 56% of the mice. Microarray analysis revealed several genes differentially expressed between the fallopian tube of mogp–TAg and wild‐type (WT) C57BL/6. One of these genes, Top2a, which encodes topoisomerase IIα, was shown by immunohistochemistry to be concurrently expressed with elevated p53 and was specifically elevated in mouse STICs but not in the surrounding tissues. TOP2A protein was also found elevated in human STICs, low‐grade and high‐grade serous carcinoma. The mouse model reported here displays a progression from normal tubal epithelium to invasive HGSC in the ovary, and therefore closely simulates the current emerging model of human ovarian HGSC pathogenesis. This mouse therefore has the potential to be a very useful new model for elucidating the mechanisms of serous ovarian tumourigenesis, as well as for developing novel approaches for the prevention, diagnosis and therapy of this disease. Published 2014. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Collaboration


Dive into the Elin Lehrmann's collaboration.

Top Co-Authors

Avatar

Kevin G. Becker

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Yongqing Zhang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

William H. Wood

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Myriam Gorospe

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jean Lud Cadet

National Institute on Drug Abuse

View shared research outputs
Top Co-Authors

Avatar

Kotb Abdelmohsen

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Michael T. McCoy

National Institute on Drug Abuse

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge